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Abstract 
Background: Phantom limb pain (PLP) is a debilitating condition for which no effective treatment has 
been found. We hypothesized that reengagement of central and peripheral circuitry involved in motor 
execution could reduce PLP via competitive plasticity and reversal of cortical reorganization. 
Methods: Fourteen patients with intractable chronic PLP, for whom conventional treatments failed, 
received 12 sessions of phantom motor execution in four hospitals using machine learning and 
augmented/virtual reality (AR/VR). Changes in intensity, frequency, duration, quality, and intrusion of 
PLP were assessed using the numeric rating scale (NRS), the pain rating index (PRI), and the weighted 
pain distribution (WPD) scale. Changes in medication and prostheses were also monitored.  Follow-up 
interviews were done at 1, 3, and 6 months after the last session. 
Results: After twelve sessions patients showed statistically and clinically significant improvements in all 
PLP metrics.  PLP decreased from pre-treatment to last treatment session by 47% (σ=39%; absolute 
x=̄1·0, σ=0·8; p=0.001) for WPD, 32% (σ=38%; absolute x=̄1·6, σ=1·8; p=0.007) for NRS, and 51% (σ=33; 
absolute x=̄9·6, σ=8·1; p=0·0001) for PRI. The NRS for intrusion of pain in activities of the daily living and 
sleep was reduced by 43% (σ=37%; absolute x=̄2·4, σ=2·3; p=0·004) and 61% (σ=39%; absolute x=̄2·3, 
σ=1·8; p=0·001), respectively. Two out of four patients who were on medication reduced their intake in 
grams by 81% and 33%. Improvements remained 6 months after the last treatment. 
Interpretation: Our findings suggest potential value in motor execution of the phantom limb as a 
treatment for PLP. Promotion of phantom motor execution aided by machine learning, AR/VR, and 
gaming, is a non-invasive, non-pharmacological and engaging treatment with no identified side effects at 
present. 
Funding: VINNOVA, Promobilia foundation, Jimmy Dahlstens Fond, PicoSolve, and Innovationskontor 
Väst. 
Introduction 
In addition to the functional challenges caused by the amputation of an extremity, patients often 
develop painful sensations perceived as originating from the missing limb, hence the name, phantom 
limb pain (PLP). Although central and peripheral factors have been implicated in the genesis of such 
neuropathic pain, the former is believed to be the major contributor.1,2 Flor et al. showed that PLP is 
closely related to neuroplastic changes in at least the primary somatosensory cortex.3 Whereas this 
finding has emerged repeatedly in studies by Flor’s group4–6 and others,7 Makin et al. found that rather 
than cortical reorganization, reduced inter-hemispheric functional connectivity might be the major 
contributor to PLP.8 In either case, these findings suggest central malplasticity as responsible for 
maintaining PLP. Neuroplasticity-based approaches for the relief of PLP, such as motor imagery and 
mirror therapy, ultimately aim to regain brain circuitry from pain. Here, we investigated a novel approach 
that overcomes methodological limitations of previous treatments by ensuring that central and 
peripheral mechanisms in motor control are activated during the therapy. 
Motor imagery along with meditation has been found to normalize previously altered cortical maps and 
reduced PLP.7 However, motor imagery was also found to increase pain in randomized clinical studies.9,10 
These findings led to the suggestion that motor imagery should not be used alone but in combination 
with other treatments, such as mirror therapy.11 Mirror therapy by itself has been shown to be more 
effective than motor imagery,9,10 and although it is often argued that similar brain areas are activated in 
motor imagery and execution, the degree of activation is not the same.12 Recently, excitatory coupling 
between thalamus and primary motor cortex was found necessary for motor execution, but not for 
motor imagery.13 The difference in activation networks between motor execution and imagery extends 
to the peripheral circuitry. These findings led us to hypothesize that true motor execution of the 
phantom would provide a more integral normalization (cortical, sub-cortical and peripheral circuits), and 
therefore potentially relieve pain in patients for whom conventional approaches have failed. 
We have shown the feasibility of decoding the execution of phantom movements (motor volition of the 
missing limb) using patterns of myoelectric activity at the stump, despite the fact that the distal muscles 
originally responsible for such movements are lost due to the amputation.14,15 For example, the 
synergistic muscular activation at the stump of a transhumeral amputee produce distinctive patterns for 
different phantom hand movements, thus making it possible for machine learning algorithms to infer 
motor volition using information from above-elbow musculature. In this way, myoelectric pattern 
recognition (MPR) allows the direct use of phantom movements in rehabilitation tasks purposely based 
in motor execution of the phantom limb, further referred to as phantom motor execution. 
Visual feedback has been found to facilitate phantom movements16 and it can potentially induce the 
illusion of a restored body representation. Therefore, we have combined MPR with Augmented Reality 
(AR) to provide appropriate and timely visual feedback. Using a conventional webcam and monitor, 
patients can observe themselves with a virtual arm in the anatomically correct location of the missing 
arm. Congruent location and orientation of the limb is known to be fundamental for perceptual 
illusions.17 A fiducial marker in the patient's stump provides guidance for moment to moment positioning 
of the virtual arm. Therefore, the patient can move freely while preserving the virtual arm in the 
anatomically correct placement. MPR then allows the virtual arm to respond to individual or 
simultaneous phantom movements under control of the patient.18 In this approach, visual feedback not 
only serves to provide a visual illusion of body completeness, but also informs the motions resulting from 
patterns of muscular activation, patterns that the patient is dynamically adapting to achieve a variety of 
movements. In addition, using MPR for control and virtual environments for visualization allows 
engaging therapeutic tasks (“serious gaming”) to be implemented in order to promote phantom motor 
execution. This concept was first introduced in the case study of one patient with intractable chronic 
PLP,14 the results of which motivated the current multi-center study in similar chronic PLP suffers for 
whom no other approach had been effective. 
The therapy proposed here (phantom motor execution) deviates from the mirror concept due to its 
independence from the contralateral limb, which also makes it equally valid for bilateral amputees. The 
main difference relies on requiring appropriate muscular activation in the affected limb, as opposed to 
using the healthy contralateral. Phantom motor execution and mirror therapy request patients to 
perform movements with the phantom limb, however, in only the former the actual execution of 
movement is an inherent component necessary for the treatment to take place. In mirror therapy, it is 
enough for the patient to move their healthy arm to produce movement in the reflected limb, however 
whether the patient is actually engaging the appropriate brain areas in execution of phantom 
movements is unknown. 
Previous approaches based on virtual or augmented reality use cameras or instrumented gloves in the 
able contralateral limb,19–21 which makes these solutions methodologically equivalent to mirror therapy. 
Motion tracking systems have been suggested as an alternative source for control,22 and although in this 
case the affected limb is used to provide the location of the virtual one, important distal movements of 
the phantom limb (e.g. hand open) cannot be inferred using said technology. Overall, the effectiveness 
of previous virtual approaches have been moderate and limited to case studies with short-term follow-
up (two or four weeks),20,21 with a single larger study of 14 patients with no follow-up.22 In the present 
study, follow-up was performed at one, three, and six months after the last treatment session. 
Methods 
Participants 
Fourteen individuals with upper limb amputation afflicted by refractory chronic PLP participated in this 
study (Table 1). Their mean (x)̄ age was 50 years old (median x=̃52, standard deviation σ=14, range R=26-
74). They have experienced PLP since soon after their amputation in average ten years at inclusion (x=̃5, 
σ=11, R=2-36). Patients were treated previously with at least one clinically used method with no 
beneficial outcome for an average of six years after their last treatment and before inclusion (x=̃3, σ=7, 
R=0·1-22). The level of amputation was equally transhumeral and transradial. Two of the patients were 
bilateral amputees but only the limb with highest pain was treated in order to keep an equivalent 
administration regime. Ethical approval for this study was granted by the ethical committees of Västra 
Götalandsregionen in Sweden, and University Rehabilitation Institute in Slovenia. All subjects provided 
written informed consent prior to inclusion. Subjects were told about the possibility of a transitory pain 
increment as observed in previous work.14 They were also informed about the research nature of this 
procedure where the outcome would be uncertain. This was done to reduce potential placebo effects 
due to expectation.23 





















Trauma TH 30 1·9 1·8 4 MT, TENS, Pharma. 0·6 - - 
Trauma TR 26 4·4 4·3 3 MT, TENS, Pharma. 3·9 - - 
Trauma TR 49 4·3 3·7 7 MT, Imp. Nstim., Pharma. 4·1 - - 
Infection TH-Bi 74 10·2 10·0 5 MT, TENS, Acup., Pharma. 2·1 Gabapentin 3·8 
Trauma TH 62 36·3 36·3 5 MT, Acup., Pharma. 0·1 - - 
Trauma TR 52 3·3 3·2 8 MT, TENS, Pharma. 1·8 Morphine 2·7 
Trauma TH 60 31·2 31·0 5 MT, Acup., Medit., Med. 19·1 - - 
Trauma TH-Bi 56 25·4 25·0 6 TENS, Acup., Pharma. 21·8 - - 
Trauma TR 51 4·9 4·5 5 MT 5·3 - - 
Trauma TR 69 5·7 5·4 2 Heat, Pharma. 5·4 - - 
Trauma TH 28 3·6 3·6 6 TENS, Snoezelen, Pharma. 2·9 Lyrica 2·4 
Tumor TH 48 2·0 2·0 4 TENS, Pharma. 0·3 Lyrica 2·0 
Trauma TR 52 3·8 3·8 6 TENS, Pharma. 2·0 - - 
Trauma TR 47 9·3 9·3 7 TENS, Pharma. 9·2 - - 
Mean (x)̄  50·3 10·4 10·3 5·2  5·6  2·7 
Standard Dev. (σ) 13·9 11·1 11·1 1·6  6·5  0·7 
Median (x)̃  51·5 4·7 4·4 5·0  3·4  2·5 
Abbreviations: amputation (Amp.), transhumeral (TH), transradial (TR), bilateral (Bi), phantom limb pain (PLP), numeric rating scale (NRS), treatment 
(treat.), mirror therapy (MT), transcutaneous electrical nerve stimulation (TENS), medications (Pharma.), implanted neurostimulator (Imp. Nstim.), 
acupuncture (Acup.), meditation (Medit.), previous treatment last session (PTLS). Snoezelen refers to multisensory stimulation therapy, which does not 
necessarily include sensory discrimination, and in the case of amputees, no appropriate tactile stimulation.  
Evaluation metrics 
The pain evaluation variables included the following: the numeric rating scale (NRS, 0 “none” to 10 
“maximum”), used as a common tool to evaluate the intensity of pain at present; the pain rating index 
(PRI, 0 to 75) formed by the summed contribution of 15 qualities of pain as in the short-form McGill Pain 
Questionnaire,24 and scored individually using the present pain intensity scale (PPI,25 0 “none” to 5 
“excruciating”); the weighted pain distribution (WPD,14 0 “none” to 5 “maximum”) aimed to capture the 
time-varying nature of chronic pain by adding the contributions of weighted portions of time spent in six 
pain levels (PPI25); and pain frequency was measured using a study-specific descriptive scale of seven 
steps: ‘never’, ‘once per month’, ‘once per week’, ‘few times per week’, ‘once per day’, ‘few times per 
day’, and ‘always’. In addition, the intrusion of PLP in activities of daily living (ADL) and sleep was 
measured by one question each, and scored on the NRS. Changes in prosthetic hardware and medication 
were monitored during the study. Statistical significance in quantitative measures were calculated using 
the Wilcoxon Signed-Rank test, and changes in the incidence of the different qualities of pain were 
evaluated by the Sign test (see extended methods). 
An important methodological feature in our evaluation of pain was to conduct the interview before each 
treatment session. This had the purpose of capturing the analgesic effects at a longer term (between 
sessions), as opposed to immediately after the intervention when the highest improvement is known to 
peak thus biasing the interpretation of clinical relevance. We considered this to be of particular 
importance when treating chronic conditions such as PLP. 
Interventions 
Patients with known chronic intractable pain were recruited at three clinics in Sweden and one in 
Slovenia: Sahlgrenska University Hospital in Gothenburg, Örebro University Hospital in Örebro, 
BräckeDiakoni Rehabcenter Sfären in Stockholm, and the University Rehabilitation Institute in Ljubljana. 
Therapists at these clinics were introduced to the technology with one practical demonstration and were 
monitored by at least the lead author during the first intervention of their first patient. The therapists 
conducted the rest of the interventions independently following the study protocol and returned a 
signed case report form at the end of the study. 
All patients received an intervention twice per week except for one who had it daily. Each session lasted 
two hours and consisted of 1) pain evaluation, 2) placement of the electrodes and fiducial marker, 3) 
practice motor execution in AR, 4) gaming by racing car using phantom movements, and 5) matching 
random target postures of a virtual arm in VR (Figure 1 and Video 1). Steps 3 to 5 were repeated for 
different movements following three levels of difficulty: A) two movements forming one degree of 
freedom (DoF); B) two to four DoF; and C) two or more DoF simultaneously. Clinicians were instructed to 
advance the level of difficulty once the previous level was accomplished successfully, and revert to the 
previous level if the patient showed considerable difficulty accomplishing the tasks (see extended 
methods). This was done to keep the phantom motor execution challenging but feasible as it is known 
that mental effort is required for plasticity to take place. The treatment consisted of 12 sessions and 
follow-up interviews at one, three, and six months after the last session. 
A user-friendly system was developed for independent use at the clinics (software and hardware). This 
system named Neuromotus was based on the open source platform BioPatRec,26 where algorithms for 
the prediction of individual and simultaneous movements18 are implemented together with virtual 
environments and gaming control interfaces. 
Role of the funding source 
The funders had no role in study design, data collection, data analysis, data interpretation, or writing of 
the report. The corresponding authors had full access to all the data in this study and had final 
responsibility for the decision to submit for publication. 
Results 
Overall continuous reduction of PLP was measured by all metrics (Figure 2). Average improvement at the 
last treatment session was recorded by the WPD (relative x=̄47%, σ=39%; absolute x=̄1·0, σ=0·8; 
p=0·001), NRS (relative x=̄32%, σ=38%; absolute x=̄1·6, σ=1·8; p=0·007), and PRI (relative x=̄51%, σ=33%; 
absolute x=̄9·6, σ=8·1; p=0·0001). Reduction in intensity and quality of pain was found in all patients (PRI; 
x=̄51%, σ=33%; p=0·0001); a positive change in the time-intensity profile was found in 12 patients (WPD; 
56%, σ=35%; p=0·001); and, reduction of pain intensity at present was found in nine patients (NRS; 55%, 
σ=27%; p=0·004). Additionally, reduction in NRS of at least two points was found in eight patients. 
Improvements in time-variation (WPD) and pain intensity at present (NRS) were maintained at all of the 
follow-ups. The average improvement measured by PRI at the last treatment session decreased by 2%, 
6%, and 24% at one, three, and six month follow-ups, respectively (Figure 2).  
Reduction in PLP was also found by the change in the number of patients reporting fifteen different 
qualities of pain (PRI) before and after treatment (Figure 3). Thirteen of such pain qualities showed 
reduced occurrence in the population. “Stabbing” and “tiring-exhausting” were found significantly less 
prevalent after treatment (p=0·016). 
Thirteen patients reported that PLP interfered with their ADL and sleep at inclusion (NRS); such intrusion 
was reduced on average by 43% (σ=37%; absolute x=̄2·4, σ=2·3; p=0·004) and 61% (σ=39%; absolute 
x=̄2·3, σ=1·8; p=0·001), respectively (Figure 4). After treatment, eight patients (62%) reported less 
interference in ADL by at least two points in NRS (representing a reduction of x=̄67%, σ=26%, p=0·004). 
Similarly, 11 patients (85%) reported less interference in sleep by an average of 72% (σ=32%, p=0·001). 
The improvements remained at the one, three, and six month follow-ups (Figure 4). In addition, the 
intake of pain medication was reduced by 81% and 33% grams in two out of four patients who were 
continuously medicated for at least two years (reduction relative to the initial dose). 
The profile of PLP frequency showed a positive change after treatment and at all follow-ups (Figure 5). 
One patient was unavailable for the third month follow-up, and a different one for the sixth month 
follow-up (computations were done accordingly).  
Statistically significant correlations of moderate strength were found between WPD (duration and 
intensity), PRI (quality and intensity), and NRS (present intensity), as well as in the intrusion of PLP in the 
patients’ ADL and sleep (p<0·0001), Figure 6 (online). Normalized changes in WPD, NRS, PRI, intrusions in 
ADL and sleep along the treatment and follow-ups are shown in Figure 6 (online). 
Discussion 
In this study we examined the effectiveness of a novel therapy for PLP based on the promotion of 
phantom motor execution. This non-invasive approach exploits principles of brain plasticity reduced PLP 
by approximately 50% in chronic sufferers from whom conventional treatments failed. Moreover, the 
intrusion of PLP in ADL and sleep was also reduced by an average of 50%. 
All the patients included in this study were first treated with other methods for a significant amount of 
time prior to phantom motor execution (x=̄6 years). It is thus reasonable to expect little to no carry over 
effects from previous therapies. Similarly, since this group of patients had suffered from chronic PLP for 
an average of ten years, pain relief owing to "natural history" or "regression to the mean" effects is 
unlikely. In addition, patients who were under medication had already been on it for over two years, 
they had no increase of dosage during the study, and therefore pain changes due to medications are also 
unlikely. Placebo effects cannot be disentangled in this study, however, the persistent relief of PLP after 
six months makes it less likely to be caused by such effects. Nevertheless, none of the aforementioned 
alternative explanations can be fully rejected by the evidence presented in this study due the lack of a 
control group. An additional limitation of this study is that the follow-ups were conducted by the same 
clinicians who administered the interventions, which can be regarded as potential source of bias. 
A drawback of the technology proposed here is that volitional control of musculature at the stump is 
necessary, thus patients with nerve injuries where no muscular activity can be elicited cannot utilize this 
technology. Similarly, patients with shoulder disarticulation may not have sufficient musculature to allow 
for the prediction of distal movements unless recipients of targeted muscle reinnervation.27 Recording of 
weak muscular contractions is technologically feasible; however, the extent at which such activity can be 
used in this treatment must be determined for each individual case, particularly when excessive soft, fat, 
and scar tissues are present. In this study, patients with high transhumeral amputations were treated 
with the inclusion criteria that at least a portion of the biceps or triceps muscles were viable. Appropriate 
motor volition of the phantom hand in a shoulder disarticulation might not be possible with the present 
approach, but this must be investigated further.  
Pain improvement 
Reduction of pain by 50% or two points in NRS have been suggested as clinically relevant outcomes.28 
The improvements found in this study on intractable chronic PLP suffers were of approximately 50%, and 
more than half of the patients improved by at least two points in NRS. Different pain measures were 
used to capture the complex profile of chronic PLP considering intensity, duration, frequency, quality and 
intrusion. Continuous improvement was measured in all these metrics for the twelve interventions, and 
was still observable at the last follow-up session. It is therefore arguable that a longer treatment regime 
(more sessions) would further decrease PLP, particularly considering that these patients had spent an 
average of ten years in a maladapted painful state. 
All but one patient reported a perceived improvement in their PLP state relative to prior treatment. This 
patient reported a stressful life situation during the study period, which he believed interfered with our 
treatment attempts. Situational stress is known to be strongly related with PLP29, and therefore was 
potentially the cause of the poor improvement. Arguably, the treatment might have prevented the 
exacerbation of PLP during this period of stress. The patient requested to be treated again once his 
personal problems are resolved. The patient who secondly least benefited from the treatment reported 
no change in his sustained pain (NRS) but showed improvement in PRI and the intrusion of PLP in ADL 
and sleep. The major benefit for this patient was the disappearance of “flare-ups” (short periods of high 
pain intensity), which allowed him to sleep better. Since the time spent in these high-intensity periods 
was minimal in comparison with the rest, little difference was captured by the WPD and none by the 
NRS. The improvement was mostly recorded by the PRI because the “flare-ups” were of specific qualities, 
thus their contribution to PRI disappeared along with their occurrence. This case highlights the 
importance of using different pain measures. All patients reported difficulties moving their phantom limb 
at the beginning of the trial, but were able to accomplish it after few sessions aside from this patient, 
who continue reporting considerable difficulties to open and close his phantom hand. 
Relation to non-pharmaceutical therapies 
Non-pharmacological approaches exploiting brain plasticity such as mirror therapy or motor imagery 
have shown promising results. However, despite their simplicity, low-cost, and clinical evidence, these 
therapies have not ultimately solved PLP. A common drawback of these approaches is the unchallenging 
repetitive nature of the exercises where no timely feedback is provided, mostly because the movement 
of the phantom limb cannot be monitored. 
Promotion of motor execution is a fundamental part of Constraint-Induced Movement Therapy (CIMT), a 
method which has been successful in neuromuscular rehabilitation after stroke, multiple sclerosis, and 
traumatic brain injuries.30 In CIMT, the able limb is restrained to force the patient to utilize the affected 
one. This strategy has been proven effective but is criticized for the strain placed on the patients. In the 
approach proposed here (MPR + AR/VR + gaming), the affected limb is forced to be activated but in 
contrast to the CIMT, is pleasant and entertaining. 
Graded motor imagery (GMI) which combines lateralization, motor imagery and mirror therapy has 
shown promising results in PLP and CRPS.31 The approach proposed here can potentially improve GMI 
further by making sure that motor execution takes place. GMI seems reasonable for patients where 
kinesiophobia is present due to its graded component, as well as for patients where motor imagery alone 
is perceived as painful. In the current study, patients did not report fear of movement nor pain related to 
imagination, intention, or any motor related actions. Negative results in the clinical implementation of 
GMI had been attributed to less therapist-patient contact and practice,32 which stresses the importance 
of proper translation and dissemination of therapies. In our case, we found that the design of our device 
allowed an easy translation to new centers requiring a single visit for instruction. In addition, if patients 
are asked to practice independently at home or clinic, the clinician can easily verify the time the patients 
spent using the system, thus improvement can be confidently coupled to therapy exposure and 
frequency. Moreover, gamification via AR/VR makes the approach proposed here more engaging than 
mirror therapy, GMI and CIMT. 
The technology presented in this study allows for an integrated treatment-evaluation system. In 
addition, it is potentially applicable to other conditions such as hemiparesis after stroke, impaired motor 
control due to nerve injuries, or recovery after hand surgery. In these cases, functional restoration could 
be improved by increasing neural drive to muscles. 
Potential working mechanisms 
Owing to the functional link found between cortical reorganization and PLP, therapeutic approaches 
aiming to alter the former will likely impact the latter.33 Explanations for cortical reorganization after 
amputation often emphasize sensory over motor deprivation as the principal cause. However, the motor 
cortex is equally affected (disused) and as opposed to incomplete sensory stimulation, a major part of 
appropriate motor related areas can still be engaged to produce movements in the missing limb. 
Appropriate stimulation of the sensory cortex would require a phantom map of referred sensations 
(rarely present and often incomplete), targeted sensory reinnervation, or implantation of neural 
interfaces for the direct stimulation of afferent fibers, which can only deliver limited qualities and 
locations at present.15,34 Conversely, motor execution of complex movements can be promoted non-
invasively with the approach proposed here, which also includes sensory (visual) and psychological 
(attentional) components. 
Patients were notably paying considerable attention to their stump during the first sessions, mostly to 
the afferent excitation resulting from muscular contraction while trying to modulate motor output to 
achieve a correct virtual movement. This might have also contributed to PLP relief via competitive 
plasticity as suggested in sensory discrimination approaches.35 In addition, ownership and agency of the 
virtual models might had contributed to pain relief, however, these were not explicitly measured and the 
effect was potentially variable in the different scenarios (AR versus gaming). The effect of non-
pharmacological perceptual approaches to PLP have mostly been attributed to appropriate sensory 
feedback, which is limited to visual input since natural tactile and proprioceptive information is not 
provided.  However, despite that visual feedback has shown to facilitate phantom movements, it has also 
been found not absolutely required for PLP relief.16 Carefully designed studies are still necessary to 
determine the contribution of each of these elements to pain relief. 
The hypothesis of motor-sensory incongruence states that the mismatch between motor intention, 
proprioception, and visual feedback, might be the cause of PLP in a similar way that visual-vestibular 
incongruences cause motion sickness. Based on this theory, Harris suggested that emphasizing the use of 
appropriate visual feedback would increase the effectives of pathological pain therapies.36 Our findings 
do not directly support this hypothesis since augmented reality, allegedly the most immersive situation, 
was only one third of the therapy. The common denominator at all stages was considerable phantom 
motor execution monitored in real-time with visual feedback in various forms. i.e., controlling the racing 
game did not require physiologically appropriate commands, but yet demanded distinctively different 
phantom movements.  
Similarly to CIMT, the basic mechanism of phantom motor execution forces the patient to recruit the 
necessary brain circuitry for the production of movement. CIMT cannot be used in PLP for obvious 
reasons. However, our technology does a similar job of restraining the healthy limb and forcing the use 
of the affected one with the advantage of being pleasant and entertaining. Therefore, this technology 
(MPR + AR-VR + gaming) can potentially be used to further improve CIMT or as a rehabilitation tool on its 
own. 
Cortical re-organization due to amputation is commonly explained by the effect of deafferentation, but it 
must not be forgotten that motor execution is equally affected. This treatment exploits the contribution 
of central and peripheral motor circuitry to reverse maladapted changes. The underlying mechanisms for 
which our phantom motor execution, mirror therapy, motor imagery, and GMI reduce PLP are poorly 
understood, but these approaches are all based in principles of brain plasticity. Further work is necessary 
to identify functional and structural changes caused by pain and by the intervention itself. From the 
clinical view point, additional clinical evidence is necessary to prove the efficacy of the approach 
proposed here. 
Conclusion 
Phantom limb pain (PLP) is a difficult condition to treat that can seriously hinder patients' quality of life. 
Surgical and pharmacological approaches have fallen short of providing an effective treatment while 
yielding considerable side effects. The results from this study suggest potential value in motor execution 
of the phantom limb, as a non-invasive and non-pharmacological treatment for PLP. Promotion of 
phantom motor execution aided by myoelectric pattern recognition, AR/VR, and gaming, is an engaging 
treatment which was found to reduce chronic PLP, with no identified side effects, in a group of patients 
for whom conventional treatments failed. Additional randomized clinical trials are necessary to 
rigorously prove the efficacy of this approach. 
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Figure 1. Motor Phantom Execution using MPR, AR/VR, and gaming. a) A conventional webcam provides live 
video of the patient displayed on a computer screen. A virtual limb is added to the video feed in the location 
indicated by a fiducial marker (b). Surface electrodes over the stump record synergistic muscles activation during 
motor volition of the phantom limb (phantom motor execution). Myoelectric pattern recognition is used to decode 
motor volition and voluntarily control the virtual limb. c) The patient is requested to match random target postures as 
a rehabilitation task. d) Patient playing a racing game in which the car is driven by phantom movements. See Video 1 
for demonstration of a treatment session. 
 
 
Figure 2. PLP perception during treatment and follow-ups. Insets illustrate the mean of absolute values (markers) 
with plus/minus one standard deviation (error bars) over 12 sessions and after one, three, and six month follow-ups. 
Pain metrics used were the weighted pain distribution (WPD), numeric rating scale (NRS), and pain rating index 
(PRI). Statistical significance between pre-treatment and last treatment session is shown by an asterisk (*). 
Significance was found at p=0·001 for WPD, p=0·007 for NRS, and p=0·0001 for PRI. The effect size was 1·3, 0·9, 
and 1·1 for WPD, NRS, and PRI, respectively. The mean differences (and uncertainty) were 1·0 (0·8), 1·6 (1·8), and 
9·6 (8·1) for WPD, NRS, and PRI, respectively. 
 
Figure 3. Incidence of pains. The incidence of fifteen qualities of pain as recorded by the Pain Rating Index are 
presented before and after treatment. Thirteen (87%) of such pain qualities showed a reduced occurrence in the 
population after treatment, two of which had a statistically significant change (p=0·016) shown by an asterisk (*). 
 
Figure 4. PLP intrusion in ADL and sleep. Markers represent the average PLP intrusion in activities of the daily 
living (ADL) and during sleep as measured by Numeric Rating Scale (NRS). Error bars show the standard deviation 
and statistical significance (p=0·004 for ADL and p=0·001 for sleep) is shown by an asterisk (*). The effect size was 
1·2 for the PLP intrusion in ADL, and 1·0 for intrusion in sleep. The mean differences (and uncertainty) was 2·4 
(2·3) and 2·3 (1·8) for PLP intrusion in ADL and sleep, respectively. 
 
Figure 5. Frequency of PLP perception. Change in the profile of PLP frequency before and after twelve sessions, 
as well as follow-ups at one, three, and six months (FU1-6). The 'once/week' frequency was removed for clarity as 
this was not reported. 
 
  
(ONLINE ONLY) Figure 6. Relationships between the different pain measures. Absolute values per subject and 
session were used to find linear associations among pairs of metrics (rows and columns). The Pearson’s correlation 
coefficients between each metrics are shown in red within each inset (all statistically significant at p<0·0001), which 
are also the slopes of the fitting lines. P-values for Pearson's correlation were computed by transforming the 
correlation to create a t statistic with numObs-2 degrees of freedom. Bottom left inset shows the changes in pain 
perception as the normalized average to their initial value. The average of absolute values for all subjects was 
obtained per session, and then normalized to the first session (pre-treatment). 
 
